OTIPRIO Drug Patent Profile
✉ Email this page to a colleague
When do Otiprio patents expire, and when can generic versions of Otiprio launch?
Otiprio is a drug marketed by Alk Abello and is included in one NDA. There are eight patents protecting this drug.
This drug has one hundred and fifty patent family members in twenty countries.
The generic ingredient in OTIPRIO is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Otiprio
A generic version of OTIPRIO was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OTIPRIO?
- What are the global sales for OTIPRIO?
- What is Average Wholesale Price for OTIPRIO?
Summary for OTIPRIO
International Patents: | 150 |
US Patents: | 8 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 4 |
Patent Applications: | 4,466 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OTIPRIO |
What excipients (inactive ingredients) are in OTIPRIO? | OTIPRIO excipients list |
DailyMed Link: | OTIPRIO at DailyMed |
![OTIPRIO drug patent expirations Drug patent expirations by year for OTIPRIO](/p/graph/s/t/OTIPRIO-patent-expirations.png)
![Drug Prices for OTIPRIO](/p/graph/drug-price/OTIPRIO.png)
Recent Clinical Trials for OTIPRIO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Otonomy, Inc. | Phase 2 |
Otonomy, Inc. | Phase 3 |
US Patents and Regulatory Information for OTIPRIO
OTIPRIO is protected by eight US patents.
Patents protecting OTIPRIO
Otic gel formulations for treating otitis externa
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF OTIC INFECTION OR INFLAMMATION
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PEDIATRIC PATIENTS WITH OTITIS MEDIA WITH EFFUSION UNDERGOING TYMPANOSTOMY TUBE PLACEMENT
Sterilization of ciprofloxacin composition
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alk Abello | OTIPRIO | ciprofloxacin | INJECTABLE, SUSPENSION;OTIC | 207986-001 | Dec 10, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OTIPRIO
See the table below for patents covering OTIPRIO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 6207093 | ⤷ Sign Up | |
European Patent Office | 2296632 | COMPOSITIONS ET PROCÉDÉS MODULANT L APOPTOSE À LIBÉRATION CONTRÔLÉE POUR LE TRAITEMENT DE TROUBLES OTIQUES (CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS) | ⤷ Sign Up |
South Korea | 20190026056 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 (AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS) | ⤷ Sign Up |
Russian Federation | 2010150863 | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ УШНЫХ ЗАБОЛЕВАНИЙ | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OTIPRIO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 122012000070 | Germany | ⤷ Sign Up | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
1429780 | 13C0012 | France | ⤷ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
1429780 | 132013902137451 | Italy | ⤷ Sign Up | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |